StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3028% above fair value
$692.74+5.95 (+0.87%)

Close on Nov 18, 2026Market cap $256.67BP/E 36.6Yield 0.25%

Thermo Fisher Scientific Accrued Restructuring Costs Balance by Quarter

Accrued Restructuring Costs Balance ($M)

Thermo Fisher Scientific Accrued Restructuring Costs Balance: $72M in Q2 2026, down 2.7% from a year earlier.

Latest, Q2 2026
72
Period ended Jun 30, 2026
Change on a year earlier
-2.7%
74 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
39
Documents cited below

Where the Q2 2026 figure comes from

Source: SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗

Reported in SEC 10-K / 10-Q Note 14.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccrued Restructuring Costs Balance ($M)Year on yearSource
Q2 2026Jun 30, 202672-2.7%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q1 2026Mar 31, 202665+10.2%SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗
Q4 2025Dec 31, 202570+40.0%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q3 2025Sep 30, 202585+60.4%SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗
Q2 2025Jun 30, 202574+51.0%SEC Form 10-Q (10q_2025Q2, filed 2025-08-01) ↗
Q1 2025Mar 31, 202559+15.7%SEC Form 10-Q (10q_2025Q1, filed 2025-05-02) ↗
Q4 2024Dec 31, 202450-16.7%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2024Sep 30, 202453-27.4%SEC Form 10-Q (10q_2024Q3, filed 2024-11-01) ↗
Q2 2024Jun 30, 202449-50.0%SEC Form 10-Q (10q_2024Q2, filed 2024-08-02) ↗
Q1 2024Mar 31, 202451-7.3%SEC Form 10-Q (10q_2024Q1, filed 2024-05-03) ↗
Q4 2023Dec 31, 202360+46.3%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2023Sep 30, 202373+329.4%SEC Form 10-Q (10q_2023Q3, filed 2023-11-03) ↗
Q2 2023Jun 30, 202398+553.3%SEC Form 10-Q (10q_2023Q2, filed 2023-08-04) ↗
Q1 2023Mar 31, 202355+358.3%SEC Form 10-Q (10q_2023Q1, filed 2023-05-05) ↗
Q4 2022Dec 31, 202241+141.2%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2022Sep 30, 202217+41.7%SEC Form 10-Q (10q_2022Q3, filed 2022-11-04) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Accrued Restructuring Costs Balance ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/restructuring-reserve

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.

See a number that looks wrong?